KUALA LUMPUR, Feb 2 — The European Union (EU) and Belgium have given assurances to fulfil their vaccine supply agreements with Malaysia, said Science, Technology and Innovation Minister Khairy Jamaluddin Abu Bakar.

KUALA TERENGGANU, Feb 1 — Malaysia is expected to receive the first batch of Pfizer-BioNTech coronavirus vaccine on Feb 26, said Health director-general Tan Sri Dr Noor Hisham Abdullah.

GENEVA, Jan 23 — The World Health Organisation (WHO) and makers of the Pfizer-BioNTech coronavirus vaccine announced Friday that they are ready to provide up to 40 million initial doses to poorer countries through the Covax facility.

SINGAPORE, Jan 1 — Singapore began vaccinating healthcare workers with Pfizer-BioNTech's Covid-19 vaccine on Wednesday (December 30, 2020), kicking off one of Asia's first inoculation programmes against a pandemic that has killed more than 1.7 million people globally.

RIYADH, Dec 15 — Saudi Arabia on Tuesday began registering citizens and residents for free Covid-19 vaccines, the Health Ministry said.

SINGAPORE, Dec 14 — Singapore has approved Pfizer-BioNTech's novel coronavirus vaccine and expects to receive shots by year-end, Prime Minister Lee Hsien Loong said on Monday, adding that he planned to be among the early vaccine recipients.

LONDON, Dec 9 — Britain's medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech's Covid-19 vaccine after two people reported adverse effects on the first day of rollout.

LONDON, Dec 6 — Britain is preparing to become the first country to roll out the Pfizer/BioNTech Covid-19 vaccine this week, initially making the shot available at hospitals before distributing stocks to doctors' clinics, the government said on Sunday.

LONDON, Dec 2 — Britain on Wednesday became the first country in the world to approve the Pfizer-BioNTech Covid-19 vaccine for use and said that it will be rolled out from early next week.

BRUSSELS, Nov 11 — The European Union (EU) will authorise a contract for the purchase of up to 300 million doses of the Covid-19 vaccine jointly developed by German company BioNTech and its American partner Pfizer, reported Xinhua news agency, quoting European Commission President Ursula von der Leyen on Tuesday.